Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Industry Research & Trends Analysis Report
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
According to Latest Study, the global market for Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.
China Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug market should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.
The United States Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug market should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.
In terms of type, Lipopeptide segment holds a share about % in 2024 and will reach % in 2030; while in terms of application, Hospital has a share approximately % in 2023 and will grow at a CAGR % during 2024 and 2030.
The global key manufacturers of Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug include Basilea Pharmaceutica Ltd, The Medicines Company, Theravance Biopharma, Allergan, Merck & Co., Inc and Pfizer, Inc, etc. In 2022, the global top five players hold a share approximately % in terms of revenue.
Methicillin-resistant Staphylococcus aureus (MRSA) is a common bacterial infection pathogen that is more difficult to treat due to its resistance to conventional antibiotics such as methicillin. The most commonly used and most effective antibiotics are vancomycin, norvancomycin, and teicoplanin. Secondly, for patients with contraindications or intolerance of the above drugs, other antibacterial drugs, such as sodium fusidate, can also be used. In some countries and regions, ceftazidime, tigecycline, linezolid, daptomycin, etc. can also be used, all of which have good curative effects.
This report aims to provide a comprehensive study of the global market for Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug. Report Highlights:
(1) Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug market size (sales volume & revenue), history data from 2019-2023 and forecast data from 2024 to 2030.
(2) Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug market competitive situation, sales, revenue, price and market share, from 2019 to 2023.
(3) China Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug market competitive situation, sales, revenue, price and market share, from 2019 to 2023.
(4) Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.
(5) Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug segment by type and by application and regional segment by type and by application.
(6) Global major production regions of Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug, capacity, production and trends.
(7) Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug industry supply chain, upstream, midstream and downstream analysis.
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Market segment by type, covers
Lipopeptide
Oxazolidinone
Tetracycline
Cephalosporin
Lipoglycopeptide
Folate Antagonist
Other
Market segment by application, can be divided into
Hospital
Specialist Clinic
Other
Market segment by players, this report covers
Basilea Pharmaceutica Ltd
The Medicines Company
Theravance Biopharma
Allergan
Merck & Co., Inc
Pfizer, Inc
1 Market Overview
1.1 Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Definition
1.2 Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Market Size and Forecast
1.2.1 By Revenue, Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Market Size, 2019-2030
1.2.2 By Sales Volume, Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Market Size, 2019-2030
1.2.3 Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Price Trend, 2019-2030
1.3 China Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Market Size and Forecast
1.3.1 By Revenue, China Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Market Size, 2019-2030
1.3.2 By Sales Volume, China Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Market Size, 2019-2030
1.3.3 China Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Price Trend, 2019-2030
1.4 China Percentage in Global Market
1.4.1 By Revenue, China Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Share in Global Market, 2019-2030
1.4.2 By Sales Volume, China Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Share in Global Market, 2019-2030
1.4.3 Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Market Size: China VS Global, 2019-2030
1.5 Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Market Dynamics
1.5.1 Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Market Drivers
1.5.2 Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Market Restraints
1.5.3 Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Industry Trends
1.5.4 Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Industry Policy
2 Global Competitive Landscape by Company
2.1 Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Revenue by Company, 2019-2024
2.2 Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Volume by Company, 2019-2024
2.3 Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Price by Company, 2019-2024
2.4 Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Participants, Market Position (Tier 1, Tier 2 and Tier 3)
2.5 Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Concentration Ratio
2.6 Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Mergers & Acquisitions, Expansion Plans
2.7 Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Manufacturers Product Type
3 China Competitive Landscape by Company
3.1 China Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Revenue by Company, 2019-2024
3.2 China Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Volume by Company, 2019-2024
3.3 China Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Participants, Market Position (Tier 1, Tier 2 and Tier 3)
3.4 China Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Market, Sales Percentage of Local Players VS Foreign Players (2019-2024)
3.5 Chinese Local Players, Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Domestic VS Export
3.6 China Market, Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Import & Export
3.6.1 China Market, Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Import & Export, 2019-2030
3.6.2 China Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Import & Export Trends
3.6.3 Main Sources of China Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Import
3.6.4 Export Destination of China Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug
4 Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Production by Region
4.1 Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Capacity, Production and Capacity Utilization, 2019-2030
4.2 Global Geographic Distribution of Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Manufacturers
4.3 Global Major Manufacturers, Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Capacity Expansion and Future Plans
4.4 Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Capacity by Region
4.5 Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Production by Region
4.5.1 Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Production & Forecast by Region, 2019 VS 2024 VS 2030
4.5.2 Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Production by Region, 2019-2024
4.5.3 Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Production Market Share & Forecast by Region, 2019-2030
5 Industry Chain Analysis
5.1 Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Industry Chain
5.2 Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Upstream Analysis
5.2.1 Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Core Raw Materials
5.2.2 Main Manufacturers of Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Production Mode
5.6 Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Procurement Model
5.7 Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Industry Sales Model and Sales Channels
5.7.1 Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Model
5.7.2 Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Typical Distributors
6 Sights by Type
6.1 Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Classification
6.1.1 Lipopeptide
6.1.2 Oxazolidinone
6.1.3 Tetracycline
6.1.4 Cephalosporin
6.1.5 Lipoglycopeptide
6.1.6 Folate Antagonist
6.1.7 Other
6.2 By Type, Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Market Size & CAGR, 2019 VS 2024 VS 2030
6.3 By Type, Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Revenue, 2019-2030
6.4 By Type, Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Volume, 2019-2030
6.5 By Type, Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Price, 2019-2030
7 Sights by Application
7.1 Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Segment by Application
7.1.1 Hospital
7.1.2 Specialist Clinic
7.1.3 Other
7.2 By Application, Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Market Size & CAGR, 2019 VS 2024 VS 2030
7.3 By Application, Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Revenue, 2019-2030
7.4 By Application, Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Volume, 2019-2030
7.5 By Application, Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Price, 2019-2030
8 Sales Sights by Region
8.1 By Region, Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Market Size, 2019 VS 2024 VS 2030
8.2 By Region, Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Revenue, 2019-2030
8.3 By Region, Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Volume, 2019-2030
8.4 North America
8.4.1 North America Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Market Size & Forecasts, 2019-2030
8.4.2 By Country, North America Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Market Size Market Share
8.5 Europe
8.5.1 Europe Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Market Size & Forecasts, 2019-2030
8.5.2 By Country, Europe Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Market Size & Forecasts, 2019-2030
8.6.2 By Country/Region, Asia Pacific Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Market Size Market Share
8.7 South America
8.7.1 South America Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Market Size & Forecasts, 2019-2030
8.7.2 By Country, South America Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Market Size & CAGR，2019 VS 2024 VS 2030
9.2 By Country, Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Revenue, 2019-2030
9.3 By Country, Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Volume, 2019-2030
9.4 U.S.
9.4.1 U.S. Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Market Size, 2019-2030
9.4.2 By Company, U.S. Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Volume Market Share, 2022
9.4.3 By Type, U.S. Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Market Size, Share, 2022 VS 2029
9.4.4 By Application, U.S. Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Market Size, Share, 2022 VS 2029
9.5 Europe
9.5.1 Europe Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Market Size, 2019-2030
9.5.2 By Company, Europe Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Volume Market Share, 2022
9.5.3 By Type, Europe Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Market Size, Share, 2022 VS 2029
9.5.4 By Application, Europe Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Market Size, Share, 2022 VS 2029
9.6 China
9.6.1 China Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Market Size, 2019-2030
9.6.2 By Company, China Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Volume Market Share, 2022
9.6.3 By Type, China Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Market Size, Share, 2022 VS 2029
9.6.4 By Application, China Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Market Size, Share, 2022 VS 2029
9.7 Japan
9.7.1 Japan Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Market Size, 2019-2030
9.7.2 By Company, Japan Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Volume Market Share, 2022
9.7.3 By Type, Japan Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Market Size, Share, 2022 VS 2029
9.7.4 By Application, Japan Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Market Size, Share, 2022 VS 2029
9.8 South Korea
9.8.1 South Korea Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Market Size, 2019-2030
9.8.2 By Company, South Korea Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Volume Market Share, 2022
9.8.3 By Type, South Korea Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Market Size, Share, 2022 VS 2029
9.8.4 By Application, South Korea Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Market Size, Share, 2022 VS 2029
9.9 Southeast Asia
9.9.1 Southeast Asia Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Market Size, 2019-2030
9.9.2 By Company, Southeast Asia Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Volume Market Share, 2022
9.9.3 By Type, Southeast Asia Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Market Size, Share, 2022 VS 2029
9.9.4 By Application, Southeast Asia Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Market Size, Share, 2022 VS 2029
9.10 India
9.10.1 India Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Market Size, 2019-2030
9.10.2 By Company, India Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Volume Market Share, 2022
9.10.3 By Type, India Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Market Size, Share, 2022 VS 2029
9.10.4 By Application, India Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Market Size, Share, 2022 VS 2029
9.11 Middle East & Asia
9.11.1 Middle East & Asia Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Market Size, 2019-2030
9.11.2 By Company, Middle East & Asia Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Volume Market Share, 2022
9.11.3 By Type, Middle East & Asia Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Market Size, Share, 2022 VS 2029
9.11.4 By Application, Middle East & Asia Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Market Size, Share, 2022 VS 2029
10 Manufacturers Profile
10.1 Basilea Pharmaceutica Ltd
10.1.1 Basilea Pharmaceutica Ltd Company Information, Head Office, Market Area and Industry Position
10.1.2 Basilea Pharmaceutica Ltd Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Models, Specifications and Application
10.1.3 Basilea Pharmaceutica Ltd Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.1.4 Basilea Pharmaceutica Ltd Company Profile and Main Business
10.1.5 Basilea Pharmaceutica Ltd Recent Developments
10.2 The Medicines Company
10.2.1 The Medicines Company Company Information, Head Office, Market Area and Industry Position
10.2.2 The Medicines Company Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Models, Specifications and Application
10.2.3 The Medicines Company Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.2.4 The Medicines Company Company Profile and Main Business
10.2.5 The Medicines Company Recent Developments
10.3 Theravance Biopharma
10.3.1 Theravance Biopharma Company Information, Head Office, Market Area and Industry Position
10.3.2 Theravance Biopharma Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Models, Specifications and Application
10.3.3 Theravance Biopharma Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.3.4 Theravance Biopharma Company Profile and Main Business
10.3.5 Theravance Biopharma Recent Developments
10.4 Allergan
10.4.1 Allergan Company Information, Head Office, Market Area and Industry Position
10.4.2 Allergan Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Models, Specifications and Application
10.4.3 Allergan Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.4.4 Allergan Company Profile and Main Business
10.4.5 Allergan Recent Developments
10.5 Merck & Co., Inc
10.5.1 Merck & Co., Inc Company Information, Head Office, Market Area and Industry Position
10.5.2 Merck & Co., Inc Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Models, Specifications and Application
10.5.3 Merck & Co., Inc Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.5.4 Merck & Co., Inc Company Profile and Main Business
10.5.5 Merck & Co., Inc Recent Developments
10.6 Pfizer, Inc
10.6.1 Pfizer, Inc Company Information, Head Office, Market Area and Industry Position
10.6.2 Pfizer, Inc Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Models, Specifications and Application
10.6.3 Pfizer, Inc Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.6.4 Pfizer, Inc Company Profile and Main Business
10.6.5 Pfizer, Inc Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Tables & Figures:
Table 1. Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Market Size & CAGR: China VS Global, 2019-2030, US$ Million
Table 2. Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Market Restraints
Table 3. Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Market Trends
Table 4. Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Industry Policy
Table 5. Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Revenue by Company, 2019-2024, US$ million
Table 6. Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Revenue Market Share by Company, 2019-2024
Table 7. Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Volume by Company, 2019-2024, (K Units)
Table 8. Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Volume Market Share by Company, 2019-2024
Table 9. Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Price by Company, 2019-2024, (US$/Unit)
Table 10. Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Mergers & Acquisitions, Expansion Plans
Table 12. Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Manufacturers Product Type
Table 13. China Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Revenue by Company, 2019-2024, US$ million
Table 14. China Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Revenue Market Share by Company, 2019-2024
Table 15. China Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Volume by Company, 2019-2024, (K Units)
Table 16. China Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Volume Market Share by Company, 2019-2024
Table 17. China Market, Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Production, Sales, Import and Export, 2019-2030, (K Units)
Table 18. China Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Import & Export Trends
Table 19. Main Sources of China Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Import
Table 20. Export Destination of China Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug
Table 21. Global Headquarters and Manufacturing Base of Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Manufacturers
Table 22. Global Major Manufacturers, Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Capacity Expansion and Future Plans
Table 23. Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Production & Forecast by Region, 2019 VS 2024 VS 2030, (K Units)
Table 24. Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Production by Region, 2019-2024, (K Units)
Table 25. Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Production Forecast by Region, 2024-2030, (K Units)
Table 26. Global Key Players of Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Upstream (Raw Materials)
Table 27. Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Typical Customers
Table 28. Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Typical Distributors
Table 29. By Type, Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Revenue & CAGR, 2019 VS 2024 VS 2030, US$ Million
Table 30. By Application, Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Revenue & CAGR, 2019 VS 2024 VS 2030, US$ Million
Table 31. By Region, Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Market Size, 2019 VS 2024 VS 2030, US$ Million
Table 32. By Region, Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Revenue, 2019-2030, US$ Million
Table 33. By Region, Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Volume, 2019-2030, (K Units)
Table 34. By Country, Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Revenue & CAGR，2019 VS 2024 VS 2030, US$ Million
Table 35. By Country, Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Revenue, 2019-2030, US$ Million
Table 36. By Country, Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Revenue Market Share, 2019-2030
Table 37. By Country, Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Volume, 2019-2030, (K Units)
Table 38. By Country, Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Volume Market Share, 2019-2030
Table 39. Basilea Pharmaceutica Ltd Company Information, Head Office, Market Area and Industry Position
Table 40. Basilea Pharmaceutica Ltd Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Models, Specifications and Application
Table 41. Basilea Pharmaceutica Ltd Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 42. Basilea Pharmaceutica Ltd Company Profile and Main Business
Table 43. Basilea Pharmaceutica Ltd Recent Developments
Table 44. The Medicines Company Company Information, Head Office, Market Area and Industry Position
Table 45. The Medicines Company Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Models, Specifications and Application
Table 46. The Medicines Company Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 47. The Medicines Company Company Profile and Main Business
Table 48. The Medicines Company Recent Developments
Table 49. Theravance Biopharma Company Information, Head Office, Market Area and Industry Position
Table 50. Theravance Biopharma Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Models, Specifications and Application
Table 51. Theravance Biopharma Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 52. Theravance Biopharma Company Profile and Main Business
Table 53. Theravance Biopharma Recent Developments
Table 54. Allergan Company Information, Head Office, Market Area and Industry Position
Table 55. Allergan Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Models, Specifications and Application
Table 56. Allergan Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 57. Allergan Company Profile and Main Business
Table 58. Allergan Recent Developments
Table 59. Merck & Co., Inc Company Information, Head Office, Market Area and Industry Position
Table 60. Merck & Co., Inc Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Models, Specifications and Application
Table 61. Merck & Co., Inc Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 62. Merck & Co., Inc Company Profile and Main Business
Table 63. Merck & Co., Inc Recent Developments
Table 64. Pfizer, Inc Company Information, Head Office, Market Area and Industry Position
Table 65. Pfizer, Inc Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Models, Specifications and Application
Table 66. Pfizer, Inc Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 67. Pfizer, Inc Company Profile and Main Business
Table 68. Pfizer, Inc Recent Developments
List of Figure
Figure 1. Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Picture
Figure 2. By Revenue, Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Market Size and Forecast, 2019-2030, US$ Million
Figure 3. By Sales Volume, Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Market Size and Forecast, 2019-2030, (K Units)
Figure 4. Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Price Trend, 2019-2030, (US$/Unit)
Figure 5. By Revenue, China Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Market Size and Forecast, 2019-2030, US$ million
Figure 6. By Sales Volume, China Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Market Size and Forecast, 2019-2030, (K Units)
Figure 7. China Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Price Trend, 2019-2030 (US$/Unit)
Figure 8. By Revenue, China Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Share of Global Market, 2019-2030
Figure 9. By Sales Volume, China Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Share of Global Market, 2019-2030
Figure 10. Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 11. Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2022
Figure 12. China Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 13. China Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 14. China Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2019-2024
Figure 15. Chinese Local Players, Proportion of Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Domestic VS Export, 2022
Figure 16. Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Capacity, Production and Capacity Utilization, 2019-2030
Figure 17. Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Capacity Market Share by Region, 2022 VS 2029
Figure 18. Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Production Market Share & Forecast by Region, 2019-2030
Figure 19. Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Industry Chain
Figure 20. Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Procurement Model
Figure 21. Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Model
Figure 22. Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Channels, Direct Sales and Distribution
Figure 23. Lipopeptide
Figure 24. Oxazolidinone
Figure 25. Tetracycline
Figure 26. Cephalosporin
Figure 27. Lipoglycopeptide
Figure 28. Folate Antagonist
Figure 29. Other
Figure 30. By Type, Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Revenue, 2019-2030, US$ Million
Figure 31. By Type, Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Revenue Market Share, 2019-2030
Figure 32. By Type, Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Volume, 2019-2030, (K Units)
Figure 33. By Type, Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Volume Market Share, 2019-2030
Figure 34. By Type, Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Price, 2019-2030, (US$/Unit)
Figure 35. Hospital
Figure 36. Specialist Clinic
Figure 37. Other
Figure 38. By Application, Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Revenue, 2019-2030, US$ Million
Figure 39. By Application, Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Revenue Market Share, 2019-2030
Figure 40. By Application, Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Volume, 2019-2030, (K Units)
Figure 41. By Application, Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Volume Market Share, 2019-2030
Figure 42. By Application, Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Price, 2019-2030, (US$/Unit)
Figure 43. By Region, Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Revenue Market Share, 2019-2030
Figure 44. By Region, Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Volume Market Share, 2019-2030
Figure 45. North America Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Revenue & Forecasts, 2019-2030, US$ Million
Figure 46. By Country, North America Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Revenue Market Share, 2022
Figure 47. Europe Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Revenue & Forecasts, 2019-2030, US$ Million
Figure 48. By Country, Europe Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Revenue Market Share, 2022
Figure 49. Asia Pacific Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Revenue & Forecasts, 2019-2030, US$ Million
Figure 50. By Country/Region, Asia Pacific Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Revenue Market Share, 2022
Figure 51. South America Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Revenue & Forecasts, 2019-2030, US$ Million
Figure 52. By Country, South America Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Revenue Market Share, 2022
Figure 53. Middle East & Africa Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Revenue & Forecasts, 2019-2030, US$ Million
Figure 54. U.S. Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Volume, 2019-2030, (K Units)
Figure 55. By Company, U.S. Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Market Share, 2022
Figure 56. By Type, U.S. Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Volume Market Share, 2022 VS 2029
Figure 57. By Application, U.S. Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Volume Market Share, 2022 VS 2029
Figure 58. Europe Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Volume, 2019-2030, (K Units)
Figure 59. By Company, Europe Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Market Share, 2022
Figure 60. By Type, Europe Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Volume Market Share, 2022 VS 2029
Figure 61. By Application, Europe Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Volume Market Share, 2022 VS 2029
Figure 62. China Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Volume, 2019-2030, (K Units)
Figure 63. By Company, China Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Market Share, 2022
Figure 64. By Type, China Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Volume Market Share, 2022 VS 2029
Figure 65. By Application, China Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Volume Market Share, 2022 VS 2029
Figure 66. Japan Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Volume, 2019-2030, (K Units)
Figure 67. By Company, Japan Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Market Share, 2022
Figure 68. By Type, Japan Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Volume Market Share, 2022 VS 2029
Figure 69. By Application, Japan Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Volume Market Share, 2022 VS 2029
Figure 70. South Korea Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Volume, 2019-2030, (K Units)
Figure 71. By Company, South Korea Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Market Share, 2022
Figure 72. By Type, South Korea Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Volume Market Share, 2022 VS 2029
Figure 73. By Application, South Korea Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Volume Market Share, 2022 VS 2029
Figure 74. Southeast Asia Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Volume, 2019-2030, (K Units)
Figure 75. By Company, Southeast Asia Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Market Share, 2022
Figure 76. By Type, Southeast Asia Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Volume Market Share, 2022 VS 2029
Figure 77. By Application, Southeast Asia Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Volume Market Share, 2022 VS 2029
Figure 78. India Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Volume, 2019-2030, (K Units)
Figure 79. By Company, India Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Market Share, 2022
Figure 80. By Type, India Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Volume Market Share, 2022 VS 2029
Figure 81. By Application, India Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Volume Market Share, 2022 VS 2029
Figure 82. Middle East & Asia Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Volume, 2019-2030, (K Units)
Figure 83. By Company, Middle East & Asia Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Market Share, 2022
Figure 84. By Type, Middle East & Asia Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Volume Market Share, 2022 VS 2029
Figure 85. By Application, Middle East & Asia Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Volume Market Share, 2022 VS 2029
Figure 86. Research Methodology
Figure 87. Breakdown of Primary Interviews
Figure 88. Bottom-up Approaches
Figure 89. Top-down Approaches
Research Methodology:
Methicillin-Resistant Staphylococcus Aureus (MRSA) Infection Treatment Drug Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|